CASD1

Across TCGA pan-cancer cohorts, CASD1 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CASD1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where CASD1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types CASD1 is over-expressed in tumor, although a few such as COAD and HNSC show the opposite, repressed pattern.

COAD, HNSC, and LUAD are the cancer types where CASD1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CASD1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	−1.269	<.001	8	view →
HNSC	Male	All	−0.738	<.001	6	view →
LUAD	All	All	+0.330	.002	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CASD1–COAD

Open the COAD breakdown →